12 OCTOBER 2006

NEW ZEALAND GAZETTE, No. 116

3459

Product:
Glivec
Active Ingredient:
Imatinib mesilate 59.75mg equivalent to 50mg imatinib base
Dosage Form:
Capsule
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer:
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Glivec
Active Ingredient:
Imatinib mesilate 119.5mg equivalent to imatinib base 100mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer:
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Glivec
Active Ingredient:
Imatinib mesilate 478mg equivalent to imatinib base 400mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Lexapro
Active Ingredient:
Escitalopram oxalate 12.77mg equivalent to Escitalopram 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers:
H Lundbeck A/S, Ottiliavej 9, Valby, Denmark
Patheon France S.A., Bourgoin-Jallieu, France

Product:
Lexapro
Active Ingredient:
Escitalopram oxalate 19.16mg equivalent to Escitalopram 15mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:
H Lundbeck A/S, Valby, Denmark

Product:
Lexapro
Active Ingredient:
Escitalopram oxalate 25.54mg equivalent to Escitalopram 20mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:
H Lundbeck A/S, Valby, Denmark

Product:
Lexapro
Active Ingredient:
Escitalopram oxalate 6.39mg equivalent to Escitalopram 5mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:
H Lundbeck A/S, Valby, Denmark

Dated this 6th day of October 2006.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7029

Inland Revenue

Tax Administration Act 1994

Notice of Determination of Tax Depreciation Rates

1. This is a notice made under section 91AAG (6) of the Tax Administration Act 1994 of a depreciation determination issued by the Commissioner of Inland Revenue under section 91AAF of that Act.

2. "Determination DEP55: Tax Depreciation Rates General Determination Number 55" relating to "psychological testing sets" used in the medical industry was signed on 27 September 2006, and will appear in Inland Revenue’s Tax Information Bulletin, Vol. 18, No. 10, of November 2006.

3. A copy of the determination may be obtained by writing to the Manager, Field Liaison & Communication (Office of the Chief Tax Counsel), National Office, Inland Revenue, P.O. Box 2198, Wellington.

RANGI KRISHNAN, Manager, Field Liaison & Communication (Office of the Chief Tax Counsel).

go6940

Notice of Determination of Tax Depreciation Rates

1. This is a notice made under section 91AAG (6) of the Tax Administration Act 1994 of a depreciation determination issued by the Commissioner of Inland Revenue under section 91AAF of that Act.

2. "Determination DEP56: Tax Depreciation Rates General Determination Number 56" relating to metal speed humps was signed on 27 September 2006, and will appear in Inland Revenue’s Tax Information Bulletin, Vol. 18, No. 10, of November 2006.

3. A copy of the determination may be obtained by writing to the Manager, Field Liaison & Communication (Office of the Chief Tax Counsel), National Office, Inland Revenue, P.O. Box 2198, Wellington.

RANGI KRISHNAN, Manager, Field Liaison & Communication (Office of the Chief Tax Counsel).

go6939